Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2005
03/22/2005US6869608 Peptides derived from a retrovirus of the HIV group and their use
03/22/2005US6869568 Functional assay of high-density lipoprotein
03/22/2005US6869532 Nucleic acid binding matrix
03/22/2005US6868954 Method and apparatus for document processing
03/22/2005CA2127541C Recombinant swinepox virus
03/22/2005CA2121680C Screening method for identifying women at increased risk for preterm delivery
03/19/2005CA2441723A1 Viral concentration process
03/17/2005WO2005024696A2 Method and system for clustering and rescaling for molecular analysis
03/17/2005WO2005024695A2 Methods for encoding non-biological information on microarrays
03/17/2005WO2005024603A2 Methods for detecting, diagnosing and treating human renal cell carcinoma
03/17/2005WO2005024426A2 HIGH-THROUGHPUT-ASSAY WITH HIGH SENSITIVITY FOR MEASURING OF THE ACTIVITY OF β-ADRENERGIC RECEPTOR KINASE AND FOR DETERMINING THE IMPACT OF TEST SUBSTANCES ON SUCH ACTIVITY
03/17/2005WO2005024422A2 Methods for identifying inhibitors
03/17/2005WO2005024419A1 Convenient disease diagnosis and tailormade treatment
03/17/2005WO2005024418A2 Novel markers for alternatively activated macrophages
03/17/2005WO2005024386A2 Use of photopolymerization for amplification and detection of a molecular recognition event
03/17/2005WO2005024380A2 Method and system for assaying transferase activity
03/17/2005WO2005024068A2 Allele-specific sequence variation analysis
03/17/2005WO2005024067A2 Genetic analysis for stratification of breast cancer risk
03/17/2005WO2005024066A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
03/17/2005WO2005024065A2 Cationic dye compound for detecting nucleic acid double strand, and detection method and apparatus using same
03/17/2005WO2005024064A2 A detection method for autism and related disorders
03/17/2005WO2005024063A1 Method of diagnosis of obesity
03/17/2005WO2005024062A2 Method for the identification of attenuating lesions in pathogens
03/17/2005WO2005024060A1 Diagnosis of risk of breast cancer
03/17/2005WO2005024059A2 Methods for identifying compounds for inhibiting fever
03/17/2005WO2005024058A2 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds
03/17/2005WO2005024057A1 Method of identifying a compound that changes the amyloid-beta precursor protein processing in a cell
03/17/2005WO2005024056A2 Method for the detection of cytosine methylations in dna with the aid of scorpion primers
03/17/2005WO2005024055A1 Methods of diagnosis and prognosis of ovarian cancer ii
03/17/2005WO2005024054A1 Diagnostic marker for ovarian cancer
03/17/2005WO2005024053A1 Nucleic acid detection assay
03/17/2005WO2005024052A1 Method of determining amount of cholesterol ester
03/17/2005WO2005024051A1 Cell-based assay for identifying peptidase inhibitors
03/17/2005WO2005024050A1 Analytical methods for determination of proteolytic cleavage at specific sites
03/17/2005WO2005024049A1 Fluorescent probe
03/17/2005WO2005024048A1 Blood and urine test
03/17/2005WO2005024046A2 Methods of detection and notification of bioagent contamination
03/17/2005WO2005024045A2 Primers for use in detecting beta-lactamases
03/17/2005WO2005024043A2 Methods for identifying, diagnosing, and predicting survival of lymphomas
03/17/2005WO2005024042A2 Aptamers and methods for their in vitro selection and uses thereof
03/17/2005WO2005024040A2 TARGET AND METHOD FOR INHIBITION OF BACTERIAL RNA POLYMERASE: MINIMIZED DERIVATIVES OF PEPTIDE ANTIBIOTIC MccJ25
03/17/2005WO2005024030A1 Rodent expression systems utilising polyoma virus and epstein barr virus sequences
03/17/2005WO2005024029A2 Plants having modified growth characteristics and method for making the same
03/17/2005WO2005024023A1 Brain tumor marker and method of diagnosing brain tumor
03/17/2005WO2005024021A1 Compositions, methods, and kits for assembling probes comprising coded molecular tags
03/17/2005WO2005024020A1 Method of screening carcinogenecity of chemical
03/17/2005WO2005024014A1 The agent for assaying analyte of patient by enzyme
03/17/2005WO2005024011A2 Novel ubp8rp polypeptides and their use in the treatment of psoriasis
03/17/2005WO2005024002A1 Recombinant production of antimicrobial agents
03/17/2005WO2005023995A2 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
03/17/2005WO2005023993A2 Methods and compositions for generation of germline human antibody genes
03/17/2005WO2005023990A2 Trans-splicing mediated photodynamic therapy
03/17/2005WO2005023986A2 Microrna as ligands and target molecules
03/17/2005WO2005023985A2 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof
03/17/2005WO2005023983A2 Genes having lineage specific variations in copy number and methods of identifying same
03/17/2005WO2005023837A2 Ebola peptides and immunogenic compositions containing same
03/17/2005WO2005023835A2 Modulators of transmembrane protease serine 6
03/17/2005WO2005023786A1 Water-soluble tetrazolium compounds
03/17/2005WO2005023297A1 Composition for the prophylaxis/treatment of hbv infections and hbv-mediated diseases
03/17/2005WO2005023292A1 Methods of treating restenosis
03/17/2005WO2005023202A2 Tumor suppressor lkb1 kinase directly activates amp-activated kinase
03/17/2005WO2005023199A2 Socs-3 promoter methylation in cancer
03/17/2005WO2005023180A2 Method for detecting cancer cells and monitoring cancer therapy
03/17/2005WO2005023177A2 Human monoclonal antibodies against bacillusanthracis protective antigen
03/17/2005WO2005023091A2 Method for non-invasive prenatal diagnosis
03/17/2005WO2005023083A2 Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
03/17/2005WO2005012543A3 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation
03/17/2005WO2005001416A3 High throughput assay of lp-pla2 activity
03/17/2005WO2004111271A3 Means and method for the detection of target nucleotide sequences using ligation assays with improved oligonucleotide probe pairs
03/17/2005WO2004111217A3 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products
03/17/2005WO2004106547A3 Fast method for detecting micro-organisms in food samples
03/17/2005WO2004106488A3 Gene expression suppression agents
03/17/2005WO2004100636A3 Method for modifying transcription and/or translation in an organism
03/17/2005WO2004092399A3 Real-time polmerase chain reaction-based genotyping assay for single nucleotide polymorphism
03/17/2005WO2004087867A3 Methods for the identification of inhibitors of serine acetyltransferase activity in plants
03/17/2005WO2004084797A3 Type 2 diabetes mellitus-associated gene and utilization of the same
03/17/2005WO2004076675A3 Glutamate transport modulatory compounds and methods
03/17/2005WO2004076619A3 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
03/17/2005WO2004072235B1 Cotton event mon 88913 and compositions and methods for detection thereof
03/17/2005WO2004058815A3 Centrosome-associated protein and applications thereof
03/17/2005WO2004054601A3 Fwd, pp2c1, adk3, cg3860, cdk4, cg7134, eip75b involved in the regulation of energy homeostasis
03/17/2005WO2004053085A3 Identification of genes involved in angiogenesis, and development of an angiogenesis diagnostic chip to identify patients with impaired angiogenesis
03/17/2005WO2004046164A3 Unique recognition sequences and methods of use thereof in protein analysis
03/17/2005WO2004044177A3 Expression profiling based on histocultures
03/17/2005WO2004025259A3 Site-specific labeling of affinity tags in fusion proteins
03/17/2005WO2004022729A8 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
03/17/2005WO2004018701A3 Haplotype structures of chromosome 21
03/17/2005WO2003097811A3 Cellular gene targets for controlling cell growth
03/17/2005WO2003089899A3 Probes for detecting tumor cells
03/17/2005WO2003081201A3 Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
03/17/2005WO2003078575A3 Molecular switches and methods for making and using the same
03/17/2005WO2003061564A8 Gene expression profiles in liver disease
03/17/2005WO2003011898A3 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
03/17/2005WO2003004621A3 Sir2 activity
03/17/2005US20050060773 Expression vector comprising nucleotide sequences coding gene associated with plant dwarfing (RHT) for use as tool in establishing seedling development in plants
03/17/2005US20050060767 DNA shuffling to produce herbicide selective crops
03/17/2005US20050060102 Interactive correlation of compound information and genomic information
03/17/2005US20050060101 Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
03/17/2005US20050059875 Biosensor and method for bone mineral density measurement
03/17/2005US20050059808 Mixture comprising type I transmembrane protein with immunoglobulin like extracellular domain for use as tool in identifying modulator which control development, differentiation and/or physiology of mammalian immune system